Cytologic diagnosis of primary effusion lymphoma in an HIV-negative patient

Kaohsiung Journal of Medical Sciences

Volumn 24, Issue 10, 2008, Pages 548-552

  Su, Yue Chiu ^a   Chai, Chee Yin ^a,b   Chuang, Shih Sung ^c,d   Liao, Yung Liang ^c   Kang, Wan Yi ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Human herpes virus 8; Human immunodeficiency virus; Primary effusion lymphoma

Indexed keywords

CD30 ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; INTERFERON REGULATORY FACTOR 4; LACTATE DEHYDROGENASE; LATENCY ASSOCIATED NUCLEAR ANTIGEN; PREDNISONE; SYNDECAN 1; UREA; VIMENTIN; VINCRISTINE;

AGED; ANEMIA; ARTICLE; ASCITES; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTODIAGNOSIS; HUMAN; KIDNEY DYSFUNCTION; LYMPHOID CELL; MALE; PLEURA EFFUSION; PRIMARY EFFUSION LYMPHOMA; UREA NITROGEN BLOOD LEVEL;

EID: 60149085556     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70015-4     Document Type: Article

References (27)

1. Boulanger E, Hermine O, Fermand JP, et al. Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients. Am J Hematol 2004;76:88-91.
2. Ascoli V, Scalzo CC, Danese C, et al. Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men. Eur Respir J 1999;14:1231-4.
3. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-56.
4. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 1996;94:533-43.
5. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996;88:3124-8.
6. Ascoli V, Lo Coco F, Torelli G, et al. Human herpesvirus 8-associated primary effusion lymphoma in HIV-negative patients: a clinicoepidemiologic variant resembling classic Kaposi's sarcoma. Haematologica 2002;87:339-43.
7. Teruya-Feldstein J, Zauber P, Setsuda JE, et al. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. Lab Invest 1998;78:1637-42.
8. Cobo F, Hernandez S, Hernandez L, et al. Expression of potentially oncogenic HHV-8 genes in an EBV-negative primary effusion lymphoma occurring in an HIV-seronegative patient. J Pathol 1999; 189:288-93.
9. Banks PM, Warnke RA. Primary effusion lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classiffication of Tumours. Lyon: IARC Press, 2001:179-80.
10. Klepfish A, Sarid R, Shtalrid M, et al. Primary effusion lymphoma (PEL) in HIV-negative patients - a distinct clinical entity. Leuk Lymphoma 2001;41:439-43.
11. Boulanger E, Daniel MT, Agbalika F, et al. Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma. Am J Hematol 2003;73:143-8.
12. Jenkins C, Sorour Y, Blake F, et al. Human-immuno-deficiency-virus-negative, human-herpes-virus-8-negative abdominal cavity primary effusion lymphoma. Clin Oncol (R Coll Radiol) 2005;17:636-8.
13. DePond W, Said JW, Tasaka T, et al. Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol 1997;21:719-24.
14. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996;10:1358-62.
15. Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006;34:335-47.
16. Brimo F, Michel RP, Khetani K, et al. Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immumocyto-chemical differential diagnosis. Cancer 2007;111:224-33.
17. Carbone A, Gloghini A, Cozzi MR, et al. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br J Haematol 2000;111:247-57.
18. Gaidano G, Gloghini A, Gattei V, et al. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood 1997; 90:4894-900.
19. Gaidano G, Carbone A. Primary effusion lymphoma: a liquid phase lymphoma of fluid-filled body cavities. Adv Cancer Res 2001;80:115-46.
20. Niitsu N, Chizuka A, Sasaki K, et al. Human herpes virus-8 associated with two cases of primary-effusion lymphoma. Ann Hematol 2000;79:336-9.
21. Tanaka S, Katano H, Tsukamoto K, et al. HHV8-negative primary effusion lymphoma of the peritoneal cavity presenting with a distinct immunohistochemical phenotype. Pathol Int 2001;51:293-300.
22. Gaidano G, Capello D, Cilia AM, et al. Genetic characterization of HHV-8/ KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer 1999;24:16-23.
23. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
24. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996;105:221-9.
25. Komanduri KV, Luce JA, McGrath MS, et al. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol 1996;713:215-26.
26. Halfdanarson TR, Markovic SN, Kalokhe U, et al. A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy. Ann Oncol 2006;17:1849-50.
27. Luppi M, Trovato R, Barozzi P, et al. Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia 2005;19:473-6.